American Energy Announces Nicholas S. Haden as Its Chief Commercial Officer
May 09, 2022 08:00 ET | American Energy Partners, Inc.
CANONSBURG, PA, May 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – American Energy Partners, Inc. (“American Energy”) (OTC: AEPT), a diversified energy company, today announced that Nicholas Haden...
Obseva Logo highresolution.jpg
ObsEva Announces Appointment of Dr. Brandi Howard as Chief Clinical Officer
May 02, 2022 07:00 ET | ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – May 2, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...
Entourage_logo (002).jpg
Entourage Health Enhances Executive Team with Key Strategic Appointments
November 03, 2021 08:00 ET | Entourage Health Corp.
TORONTO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of...
ProQR Appoints Theresa Heggie as Chief Commercial Officer
October 04, 2021 08:00 ET | ProQR Therapeutics N.V.
Senior leader with extensive global rare disease commercialization experienceTop-line data from Phase 2/3 pivotal Illuminate trial of sepofarsen for CEP290-mediated LCA10 on track for H1 2022 ...
Auto Industry Veteran to Lead EV Charging Company’s Sales Growth
September 02, 2021 07:00 ET | JuiceBar
NORWALK, Conn., Sept. 02, 2021 (GLOBE NEWSWIRE) -- EV charging company JuiceBar today announced the appointment of Matt Tolan as its first Chief Commercial Officer to oversee all sales and revenue...
Obseva Logo4 (00000002).jpg
ObsEva appoints Clive Bertram as Chief Commercial Officer
May 06, 2021 00:55 ET | ObsEva SA
GENEVA, Switzerland and BOSTON, MA – May 6, 2021 – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive...
Freeline appoints Mark Baldry as Chief Commercial Officer
November 02, 2020 07:00 ET | Freeline Therapeutics
LONDON, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based...
Aprea logo 445pt.png
Aprea Therapeutics Promotes Gregory S. Wessels to Chief Commercial Officer and Announces Governance Changes
September 18, 2020 08:00 ET | Aprea Therapeutics
BOSTON, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics Inc., (NASDAQ: APRE), a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapeutics that...
RateLinx Logo
RateLinx Expands Leadership Team, Appoints Steve Horler Chief Commercial Officer
April 21, 2020 05:00 ET | RateLinx
MADISON, Wis., April 21, 2020 (GLOBE NEWSWIRE) -- RateLinx announced today the appointment of Steve Horler as Chief Commercial Officer effective immediately. Horler previously held the position of...
RateLinx Logo
RateLinx amplía equipo de liderazgo y nombra a Steve Horler como director comercial
April 21, 2020 05:00 ET | RateLinx
MADISON, Wis., April 21, 2020 (GLOBE NEWSWIRE) -- RateLinx anunció hoy el nombramiento de Steve Horler como director comercial, con fecha efectiva inmediata. Horler anteriormente desempeñó la...